pancreatic cancer semaglutide GLP-1s appear to cut risk. Researchers are asking why and how : NPR GLP-1 drugs linked to major

For patients who have not responded fully to semaglutide or tirzepatide, retatrutide may represent a meaningful step forward

The pharmacovigilance data revealed a significantly elevated incidence of adverse reactions in the metformin monotherapy cohort compared to the combination therapy group

If one site becomes irritated, skip it entirely until it heals

Clinical trials have not established a direct causal relationship between these medications and nocturnal hyperhidrosis

Gradual Tapering of GLP-1 Medications Instead, we recommend working with your doctor to taper off the medication gradually

holds equity in Nested Knowledge, Superior Medical Editors, and Conway Medical, Marblehead Medical and Piraeus Medical